These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1379917)

  • 1. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope.
    Tzartos SJ; Remoundos MS
    Eur J Biochem; 1992 Aug; 207(3):915-22. PubMed ID: 1379917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
    Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
    Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.
    Lennon VA; Griesmann GE
    Neurology; 1989 Aug; 39(8):1069-76. PubMed ID: 2474772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution epitope mapping and fine antigenic characterization of the main immunogenic region of the acetylcholine receptor. Improving the binding activity of synthetic analogues of the region.
    Papadouli I; Sakarellos C; Tzartos SJ
    Eur J Biochem; 1993 Jan; 211(1-2):227-34. PubMed ID: 7678806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies as site-specific probes for the acetylcholine-receptor delta-subunit tyrosine and serine phosphorylation sites.
    Tzartos SJ; Kouvatsou R; Tzartos E
    Eur J Biochem; 1995 Mar; 228(2):463-72. PubMed ID: 7705363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H; Tzartos SJ; Claudio T
    Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides.
    Tzartos SJ; Loutrari HV; Tang F; Kokla A; Walgrave SL; Milius RP; Conti-Tronconi BM
    J Neurochem; 1990 Jan; 54(1):51-61. PubMed ID: 1688377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine phosphorylation site of the acetylcholine receptor beta subunit is located in a highly immunogenic epitope implicated in channel function: antibody probes for beta subunit phosphorylation and function.
    Tzartos SJ; Valcana C; Kouvatsou R; Kokla A
    EMBO J; 1993 Dec; 12(13):5141-9. PubMed ID: 7505221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against the acetylcholine receptor gamma-subunit as site specific probes for receptor tyrosine phosphorylation.
    Tzartos SJ; Tzartos E; Tzartos JS
    FEBS Lett; 1995 Apr; 363(1-2):195-8. PubMed ID: 7537227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a cytoplasmic region of the Torpedo nicotinic acetylcholine receptor alpha-subunit by epitope mapping.
    Pedersen SE; Bridgman PC; Sharp SD; Cohen JB
    J Biol Chem; 1990 Jan; 265(1):569-81. PubMed ID: 1688436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
    Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
    J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of monoclonal antibodies to Torpedo acetylcholine receptor gamma subunits, which specifically recognize the epsilon subunit of mammalian muscle acetylcholine receptor.
    Nelson S; Shelton GD; Lei S; Lindstrom JM; Conti-Tronconi BM
    J Neuroimmunol; 1992 Jan; 36(1):13-27. PubMed ID: 1370956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.
    Karachunski PI; Ostlie N; Conti-Tronconi BM; Bellone M
    Immunology; 1994 May; 82(1):22-7. PubMed ID: 7519170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.